Start › Rak trzustki › Nowy Jork › New York City
Badania kliniczne dla Rak trzustki w mieście New York City, NY
60 badań dla Rak trzustki szuka uczestników w ośrodkach w mieście New York City i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Research Site, New York
- Research Site, New York
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekrutacjaFaza 3
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Rekrutacja
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- i 2 więcej
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 2
- Memorial Sloan Kettering Hospital, New York
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RekrutacjaFaza 3
- Columbia University Irving Medical Center, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekrutacjaFaza 1
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekrutacjaBadanie obserwacyjne
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekrutacjaFaza 2/3
- Icahn School of Medicine at Mount Sinai, New York
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekrutacjaFaza 3
- Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- i 1 więcej
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekrutacjaFaza 3
- Investigative Site US031, New York
- Investigative Site US003, New York
- Investigative Site US041, New York
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekrutacjaFaza 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekrutacjaFaza 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekrutacjaFaza 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekrutacjaFaza 2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekrutacjaFaza 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekrutacjaFaza 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekrutacjaBadanie obserwacyjne
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekrutacjaFaza 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekrutacjaFaza 2
- NYU-Manhattan, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekrutacjaFaza 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Rekrutacja
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
RekrutacjaFaza 1/2
- Mount Sinai Hospital, New York
- NYP/Weill Cornell Medical Center, New York
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Rekrutacja
- NYU Langone Health, New York
- Lenox hill Hospital, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekrutacjaFaza 1
- New York Cancer & Blood Specialists, New York
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekrutacjaFaza 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- i 2 więcej
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Memorial Sloan - Kettering Cancer Center, New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities), New York
- Weill Cornell Medical Center, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Investigative Site #103, New York
- Investigative Site #106, New York
Pancreatic Cancer Early Detection Consortium
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Irving Medical Center, New York
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RekrutacjaFaza 2
- NYU Langone Health Perlmutter Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RekrutacjaFaza 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
RekrutacjaBadanie obserwacyjne
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
RekrutacjaFaza 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekrutacjaFaza 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekrutacjaFaza 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
RekrutacjaFaza 1
- Columbia University Irving Medical Center, New York
Pancreatic Cancer Genetics
RekrutacjaBadanie obserwacyjne
- Columbia University Medical Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- Icahn School of Medicine at Mt. Sinai, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekrutacjaFaza 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Columbia University Medical Center, New York
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
RekrutacjaFaza 1/2
- Columbia University Irving Medical Center, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekrutacjaFaza 2
- Ohio State University-Telemedicine, New York
Pancreas Registry and High Risk Registry
RekrutacjaBadanie obserwacyjne
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
RekrutacjaFaza 1
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekrutacjaBadanie obserwacyjne
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Multiparametric Ultrasound Imaging Methods
RekrutacjaZapraszamy zdrowych ochotników
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekrutacjaFaza 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
RekrutacjaFaza 1
- Tisch Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekrutacjaFaza 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- Exelixis Clinical Site #5, New York
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RekrutacjaBadanie obserwacyjne
- Icahn School of Medicine at Mount Sinai, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekrutacjaFaza 1
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
RekrutacjaFaza 2
- Columbia University Medical Center, New York
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RekrutacjaFaza 2/3
- Columbia University Medical Center, New York
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
RekrutacjaFaza 2
- Icahn School of Medicine at Mount Sinai, New York
Badania dla Rak trzustki w innych miastach
- Houston, TX61 badań
- Boston, MA43 badań
- Nashville, TN39 badań
- Los Angeles, CA35 badań
- St. Louis, MO33 badań
- Arlington, VA33 badań
- Baltimore, MD31 badań
- San Antonio, TX31 badań
- Philadelphia, PA26 badań
- Tampa, FL26 badań
- Durham, NC24 badań
- San Diego, CA24 badań
Inne badania w mieście New York City
- Rak piersi136 badań
- Niedrobnokomórkowy rak płuca121 badań
- Nowotwory (wszystkie typy)109 badań
- Rak prostaty103 badań
- Nowotwór przerzutowy93 badań
- Rak jelita grubego i odbytnicy78 badań
- Rak jajnika69 badań
- Rak płuc60 badań
- Szpiczak mnogi60 badań
- Rak endometrium52 badań
- Ostra białaczka szpikowa51 badań
- Niewydolność serca51 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.